Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$5,710 Mln
P/E Ratio
47.7
P/B Ratio
11.81
Industry P/E
--
Debt to Equity
0.02
ROE
0.31 %
ROCE
29.94 %
Div. Yield
0 %
Book Value
1.98
EPS
0.52
CFO
$-120.20 Mln
EBITDA
$-284.91 Mln
Net Profit
$-287.06 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Hims Hers Health Inc (HIMS)
| 16.21 | -24.89 | -8.97 | 127.71 | 82.15 | 23.03 | -- |
|
BSE Sensex
| 1.23 | 1.57 | 3.97 | 7.26 | 11.47 | 20.39 | 11.18 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
|
|---|---|---|---|---|---|
|
Hims Hers Health Inc (HIMS)
| 169.48 | 38.85 | -2.14 | -55.14 | 47.16 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 138.95 | 11,114.40 | 12.58 | 159.08 | |
| 113.31 | 10,143.41 | 22.04 | 24.54 | |
| 122.16 | 11,423.77 | 3.51 | 110.75 | |
| 172.62 | 10,517.19 | 9.59 | 17.71 |
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and... non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California. Address: 2269 Chestnut Street, San Francisco, CA, United States, 94123 Read more
Co-Founder, Chairman & CEO
Mr. Andrew Dudum
Co-Founder, Chairman & CEO
Mr. Andrew Dudum
Headquarters
San Francisco, CA
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Hims Hers Health Inc (HIMS) stood at $ 708 Mln as on 31-Dec-24
The share price of Hims Hers Health Inc (HIMS) is $28.10 (NYSE) as of 25-Apr-2025 13:33 EDT. Hims Hers Health Inc (HIMS) has given a return of 82.15% in the last 3 years.
Hims Hers Health Inc (HIMS) has a market capitalisation of $ 5,710 Mln as on 24-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/E ratio of Hims Hers Health Inc (HIMS) is 47.70 times as on 24-Apr-2025.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Hims Hers Health Inc (HIMS) and enter the required number of quantities and click on buy to purchase the shares of Hims Hers Health Inc (HIMS).
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California. Address: 2269 Chestnut Street, San Francisco, CA, United States, 94123
The CEO & director of Mr. Andrew Dudum. is Hims Hers Health Inc (HIMS), and CFO & Sr. VP is Mr. Andrew Dudum.
There is no promoter pledging in Hims Hers Health Inc (HIMS).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,142
|
|
|
1,111
|
|
|
1,052
|
|
|
1,014
|
| Hims Hers Health Inc (HIMS) | Ratios |
|---|---|
|
Return on equity(%)
|
30.71
|
|
Operating margin(%)
|
--
|
|
Net Margin(%)
|
8.54
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Hims Hers Health Inc (HIMS) was $0 Mln.
$-0.04
(
